Quantcast
Channel: WN.com - Articles related to Noven Receives FDA Approval for Brisdelle™ (Paroxetine) Capsules, the First Nonhormonal Therapy for Vasomotor Symptoms Associated with Menopause
Viewing all articles
Browse latest Browse all 189

Research and Markets: Vasomotor Symptoms of Menopause - Pipeline Review, H2 2012 Features Players Such as Pfizer Inc. and Noven Pharmaceuticals, Inc.

$
0
0
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/8f9vgv/vasomotor) has announced the addition of Global Markets Direct's new report "Vasomotor Symptoms of Menopause - Pipeline Review, H2 2012" to their offering. “Vasomotor Symptoms of Menopause - Pipeline Review, H2 2012” Global Markets Direct's 'Vasomotor Symptoms of Menopause - Pipeline Review, H2 2012' provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Vasomotor Symptoms of Menopause, complete with latest updates, and special features on late-stage and discontinued...

Viewing all articles
Browse latest Browse all 189

Latest Images

Trending Articles



Latest Images

<script src="https://jsc.adskeeper.com/r/s/rssing.com.1596347.js" async> </script>